Hypertrophic Obstructive Cardiomyopathy: The Role of Myectomy and Percutaneous Septal Ablation in Drug-refractory Disease

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. Its prevalence is 0.2% to 0.6%. METHODS: This review is based on publications retrieved by a selective literature search and on the authors’ clinical experience. RESULTS: 70% of patients with HCM suffer from t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Dtsch Arztebl Int
Main Authors: Batzner, Angelika, Schäfers, Hans-Joachim, V. Borisov, Konstantin, Seggewiß, Hubert
Formato: Artigo
Idioma:Inglês
Publicado: Deutscher Arzte Verlag 2019
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6415619/
https://ncbi.nlm.nih.gov/pubmed/30855006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2019.0047
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares